Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs2260889 | chr13:114141062 | C/A | 4.05E-12 | 176 | 24.1 | 30.33 | 3.32 | KM Plot |
PCPG | rs2261007 | chr13:114181316 | A/T | 4.67E-12 | 176 | 24.17 | 30.63 | 3.32 | KM Plot |
PCPG | rs2261009 | chr13:114181169 | A/G | 4.67E-12 | 176 | 24.17 | 30.63 | 3.32 | KM Plot |
PCPG | rs2261120 | chr13:114146893 | A/G | 1.14E-7 | 178 | 3.7 | 29.57 | 24.17 | KM Plot |
PCPG | rs2261232 | chr13:114150592 | G/A | 5.27E-12 | 176 | 24.23 | 29.57 | 3.32 | KM Plot |
PCPG | rs2261233 | chr13:114150433 | C/G | 5.27E-12 | 176 | 24.23 | 29.57 | 3.32 | KM Plot |
PCPG | rs2261237 | chr13:114150358 | A/G | 5.27E-12 | 176 | 24.23 | 29.57 | 3.32 | KM Plot |
PCPG | rs2261241 | chr13:114149891 | T/C | 5.27E-12 | 176 | 24.23 | 29.57 | 3.32 | KM Plot |
PCPG | rs2261243 | chr13:114149792 | A/G | 5.27E-12 | 176 | 24.23 | 29.57 | 3.32 | KM Plot |
PCPG | rs2261244 | chr13:114149739 | T/C | 5.27E-12 | 176 | 24.23 | 29.57 | 3.32 | KM Plot |
PCPG | rs2261266 | chr13:114149534 | C/A | 5.27E-12 | 176 | 24.23 | 29.57 | 3.32 | KM Plot |
PCPG | rs2261267 | chr13:114149518 | G/A | 0.000434 | 175 | 24.38 | 28.95 | 3.7 | KM Plot |
PCPG | rs2261269 | chr13:114149460 | A/G | 5.27E-12 | 176 | 24.23 | 29.57 | 3.32 | KM Plot |
PCPG | rs2261372 | chr13:114179304 | T/C | 4.67E-12 | 177 | 24.17 | 30.33 | 3.32 | KM Plot |
PCPG | rs2261891 | chr13:114174755 | A/T | 0.000389 | 178 | 24.1 | 29.5 | 3.7 | KM Plot |